Skip Navigation

This Article
Right arrow Print PDF (8263K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (26)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Fischer, K.-D.
Right arrow Articles by Nowock, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fischer, K.-D.
Right arrow Articles by Nowock, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1990, Vol. 18, No. 19 5685-5693
© 1990


MOLECULAR BIOLOGY

The T->C substitution at -198 of the A{gamma}-globin gene associated with the British form of HPFH generates overlapping recognition sites for two DNA-binding proteins

Klaus-Dieter Fischer and Joachim Nowock*

Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie an der Universität Hamburg Martinistrasse 52, 2000 Hamburg 20, FRG

*To whom correspondence should be addressed

Received July 11, 1990. Revised September 3, 1990. Accepted September 3, 1990.

Defects in the developmental changes of human hemoglobin production characterized by the continued expression of fetal globin during adult life are classified as hereditary persistence of fetal hemoglobin (HPFH). Among the various molecular lesions associated with this phenotype, the non-deletion forms with point mutations In the promoter region are thought to provide mechanistic clues for {gamma}-globin gene regulation. The natural occurrence of four different base substitutions mapping within six nucleotides of a homopurine.homopyrimidlne motif in the upstream promoter region demarcate a potential control element. To assess Its importance for transcriptional activity, we compared the –202 (C->G), –198 (T->C) and –196 (C->T) HPFH mutations with the normal sequence in binding studies with nuclear proteins from erythroid and non-erythrold cells. Wildtype DNA and HPFH mutations at –202 or –196 showed only a weak protein interaction of unclear functional significance. In contrast, –198 (T->C) generated overlapping, high-affinity binding sites for two ubiquitous nuclear proteins. One cognate protein was identified as the transcription factor Sp1. The second one was termed NF-G.C as it interacted strongly with the homopolymer poly(dG).poly(dC). The generation of additional recognition sites for trans-acting factors by the -198 HPFH mutation correlated with a modest increase in promoter activity in vitro specifically with nuclear extracts from erythroid cells. The activation appears to be mediated by binding of Sp1, but it requires interaction with an erythroid-speclfic factor, most likely GF-1. Templates containing the -196 HPFH mutation showed a transcriptional activity identical to wildtype. This suggests that despite the topological proximity of the mutations, the HPFH phenotype may be established by different mechanisms.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
I. A. Olave, C. Doneanu, X. Fang, G. Stamatoyannopoulos, and Q. Li
Purification and Identification of Proteins That Bind to the Hereditary Persistence of Fetal Hemoglobin -198 Mutation in the {gamma}-Globin Gene Promoter
J. Biol. Chem., January 12, 2007; 282(2): 853 - 862.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. E. Ronchi, S. Bottardi, C. Mazzucchelli, S. Ottolenghi, and C. Santoro
Differential Binding of the NFE3 and CP1/NFY Transcription Factors to the Human [IMAGE]- and [IMAGE]-Globin CCAAT Boxes
J. Biol. Chem., September 15, 1995; 270(37): 21934 - 21941.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.